IL6 and COVID-19: These results emphasize the need for close monitoring and early detection of Aspergillus co-infection in COVID-19 patients, as well as the importance of implementing measures to prevent and manage this complication to improve patient outcomes and reduce the burden on healthcare resources. Further research is required to determine the role of steroids and IL-6 inhibitors in the increasing incidence of Aspergillus infections.